<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">79993</id>
  <title nil="true"/>
  <common-name>N-(2-(Acetylamino)ethyl)-N-(2-((1-oxohexadecyl)amino)ethyl)hexadecan-1-amide</common-name>
  <description>N-(2-(Acetylamino)ethyl)-N-(2-((1-oxohexadecyl)amino)ethyl)hexadecan-1-amide belongs to the fatty amides, a subclass of fatty acyls within the organic compounds. It is classified under the superclass of lipids and lipid-like molecules and has the chemical formula C38H75N3O3. With an average molecular weight of 622.04 g/mol, N-(2-(Acetylamino)ethyl)-N-(2-((1-oxohexadecyl)amino)ethyl)hexadecan-1-amide is a heavy molecule.</description>
  <cas>85187-60-6</cas>
  <pubchem-id>3020501</pubchem-id>
  <chemical-formula>C38H75N3O3</chemical-formula>
  <weight nil="true"/>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-04T15:16:47Z</created-at>
  <updated-at type="dateTime">2026-04-04T15:16:47Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCCCCCCCCCCCCCC(=O)NCCN(CCNC(C)=O)C(=O)CCCCCCCCCCCCCCC</moldb-smiles>
  <moldb-formula>C38H75N3O3</moldb-formula>
  <moldb-inchi>InChI=1S/C38H75N3O3/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-30-37(43)40-33-35-41(34-32-39-36(3)42)38(44)31-29-27-25-23-21-19-17-15-13-11-9-7-5-2/h4-35H2,1-3H3,(H,39,42)(H,40,43)</moldb-inchi>
  <moldb-inchikey>SMIOMPTWIHHAGO-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">622.036</moldb-average-mass>
  <moldb-mono-mass type="decimal">621.580843</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id>2287380</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM075886</chemdb-id>
  <dsstox-id>DTXSID30234376</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00038840</susdat-id>
  <iupac>N-[2-[2-acetamidoethyl(hexadecanoyl)amino]ethyl]hexadecanamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Lipids and lipid-like molecules</superklass>
  <klass>Fatty Acyls</klass>
  <subklass>Fatty amides</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0128517</sync-id>
  <structure-inchikey>SMIOMPTWIHHAGO-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000000000800000000000000000000000000004000000000004000000000002000000000000000000000000000000000000000000000002000000000000000000000000010400001000000020001000000000000000100000000000000020010000000000000000004000000000000000000000002000000000400000000040000000000000000000010080000000000000000000020840001004000000000000000000000000000000000000000028000000000000000000000000000008000004000000000000000000000000000000020000000000000000000000000000000000000000000000010400000001000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>4000800005120600010011008138a0000000000080052040003000400200880c4002005000800000000041200080000004600205808c10210244643000a00000c6110401088000000080100000720000000400004001003340000462040008000c200128004002000000000055140044200480500101410431180200025000021040081806e0820a08020250482c0008311c181244409c0a5000082060400000004310110090c01000000960056c35104ac000008801080010000800404002000010008404080022008004044001029808000000020040000960000008000204000048000881000013000000480220020050003080c2040c0000008050000006</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAAKwAAAIABBgBgAAAAAQMGAGAAAAAC
AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAA
AAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIG
AGAAAAACAgYAYAAAAAICBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQYAYAAA
AAICBgBgAAAAAgIHACgAAAADAwYAYAAAAAICBgBgAAAAAgIHAGgAAAADAgEG
ACgAAAADBAYAYAAAAAEDCAAoAAAAAwIGACgAAAADBAgAKAAAAAMCBgBgAAAA
AgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBg
AAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAIC
BgBgAAAAAgIGAGAAAAACAgYAYAAAAAEDCwABAAECAAIDAAMEAAQFAAUGAAYH
AAcIAAgJAAkKAAoLAAsMAAwNAA0OAA4PAA8QKAIPESAREgASEwATFAAUFQAV
FgAWFwAXGCAYGQAYGigCFBsgGxwoAhsdAB0eAB4fAB8gACAhACEiACIjACMk
ACQlACUmACYnACcoACgpACkqACorAEIAAAAAFwQAAAAAAAAAFg==
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:27:01Z</structure-indexed-at>
</compound>
